Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study
- PMID: 9438850
- DOI: 10.1126/science.279.5350.563
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study
Abstract
Insulin-like growth factor-I (IGF-I) is a mitogen for prostate epithelial cells. To investigate associations between plasma IGF levels and prostate cancer risk, a nested case-control study within the Physicians' Health Study was conducted on prospectively collected plasma from 152 cases and 152 controls. A strong positive association was observed between IGF-I levels and prostate cancer risk. Men in the highest quartile of IGF-I levels had a relative risk of 4.3 (95 percent confidence interval 1.8 to 10.6) compared with men in the lowest quartile. This association was independent of baseline prostate-specific antigen levels. Identification of plasma IGF-I as a predictor of prostate cancer risk may have implications for risk reduction and treatment.
Comment in
- Science. 1998 Oct 9;282(5387):199
-
Study suggests new way to gauge prostate cancer risk.Science. 1998 Jan 23;279(5350):475. doi: 10.1126/science.279.5350.475. Science. 1998. PMID: 9454344 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical